Software
IndustriesManufacturerThermo Fisher Scientific
Importance of the Topic
Audit trails play a critical role in regulated environments by providing an immutable record of all user and system actions affecting electronic data. In industries subject to GMP, GLP, or GCP regulations, secure, computer-generated, time-stamped logs are required to ensure data integrity and trace unauthorized modifications. Robust audit trail controls help organizations meet 21 CFR Part 11, EU GMP Annex 11, and other international standards while supporting sound scientific decision-making.
Study Objectives and Overview
This white paper examines the audit trail capabilities built into Thermo ScientificTM ChromeleonTM Chromatography Data System (CDS). The goals are to outline relevant regulatory requirements, demonstrate how to configure and secure audit trails, and illustrate streamlined review processes that satisfy frequent inspection expectations.
Methodology and Instrumentation
Chromeleon CDS provides three core audit domains:
- User Management logs user and privilege changes upon enabling User Mode.
- Data Audit Trail, including object versioning, triggers when a Data Vault is created.
- System Events Audit Trail captures global policy changes, service interruptions, and raw data verification failures.
All audit settings are privilege-controlled to limit modifications to authorized administrators. Date/time stamps rely on the operating system’s clock, stored in UTC and viewable in local time through unique tooltips. Instruments—both Thermo Fisher and third-party—are integrated via CDS to lock panel controls, record injection-level metadata, and maintain daily instrument event logs.
Main Findings and Discussion
Key observations include:
- Segregated audit trails streamline context-specific reviews (e.g., Sequence, Injection, Instrument logs).
- Standard Comments and privileged actions enforce user justification (“why”) for critical changes.
- Version comparison tools clearly display before/after values and support restoration of previous states.
- Centralized audit trail storage on the Domain Controller supports high availability, network-outage buffering, and backup inclusion.
- Sequence-centric architecture groups raw data, methods, metadata, and audit logs into a single unit for efficient filtering, searching, and electronic signature workflows.
Benefits and Practical Applications
Organizations adopting Chromeleon CDS audit trail controls can:
- Reduce manual effort during regulatory inspections by providing organized, searchable logs.
- Mitigate data integrity risks through privilege-based access and hashed raw data verification.
- Support process improvements via ad-hoc audit reviews and trend analysis.
- Maintain compliance with diverse global regulations through centrally managed policies.
Future Trends and Opportunities
As regulatory guidance evolves—emphasizing evidence of audit trail review and automated self-auditing—software solutions will likely integrate more intelligent analytics, AI-driven anomaly detection, and seamless linkage between audit logs and electronic signatures. Enhanced interoperability with laboratory information management systems (LIMS) and cloud-native architectures will further optimize data integrity workflows.
Conclusion
Thermo Scientific™ Chromeleon™ CDS offers comprehensive, privilege-controlled audit trail capabilities that align with current and emerging regulatory expectations. Its sequence-centric design, centralized storage, and built-in review tools enable organizations to establish efficient, scientifically robust data verification processes.
References
- U.S. FDA, 21 CFR Part 11: Electronic Records; Electronic Signatures.
- FDA, Data Integrity and Compliance with CGMP Guidance for Industry.
- OECD Advisory Document No. 17 on Good Laboratory Practice.
- EU GMP Annex 11: Computerised Systems.
- WHO Annex 5: Guidance on Good Data and Record Management Practices.
- PIC/S Draft PI 041-1: Data Management and Integrity in GMP/GDP.
- MHRA: GMP Data Integrity Definitions and Guidance for Industry.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.